Bridgewater Associates’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.9M Buy
+998,761
New +$45.1M 0.21% 79
2026
Q1
Sell
-413,699
Closed -$21.4M 1160
2025
Q4
$21.4M Sell
413,699
-60,790
-13% -$3.71M 0.08% 191
2025
Q3
$35.3M Sell
474,489
-510,759
-52% -$37.5M 0.14% 121
2025
Q2
$75.3M Buy
985,248
+484,768
+97% +$34.9M 0.3% 67
2025
Q1
$34.9M Buy
500,480
+277,783
+125% +$19.2M 0.16% 118
2024
Q4
$13.6M Buy
+222,697
New +$14.6M 0.06% 214
2023
Q1
Sell
-12,071
Closed -$314K 842
2022
Q4
$314K Buy
+12,071
New +$330K ﹤0.01% 770
2022
Q3
Sell
-15,077
Closed -$221K 977
2022
Q2
$221K Buy
15,077
+3,286
+28% +$68.5K ﹤0.01% 968
2022
Q1
$316K Buy
+11,791
New +$316K ﹤0.01% 931

Other funds holding NTNX

Bridgewater Associates's NTNX Position: Q2 2026 in Review

Bridgewater Associates opened a new position in Nutanix (NTNX) in Q2 2026: 998,761 shares worth $50.9M. The stake represents 0.21% of the portfolio and ranks #79 among its holdings. This is a return to the name: Bridgewater Associates previously reported a position in NTNX as recently as Q4 2025.

Bridgewater Associates first reported a position in NTNX in Q1 2022 and has held it in 9 quarters since. The position peaked at $75.3M in Q2 2025. 562 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

  • Bridgewater Associates held 998,761 shares of Nutanix worth $50.9M as of Q2 2026.
  • Nutanix was a new Bridgewater Associates position in Q2 2026.
  • Nutanix made up 0.21% of Bridgewater Associates's portfolio in Q2 2026, its #79 holding.
  • Bridgewater Associates first reported a position in Nutanix in Q1 2022 and has held it in 9 quarters since.
  • Bridgewater Associates's Nutanix position peaked at $75.3M in Q2 2025.
  • 562 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.